Abstract:OBJECTIVE:Whey protein (WP) has been reported to reduce body weight gain and improve glucose metabolism in obese individuals. This study aims to assess and compare the effects of WP and its hydrolysate-leucine (Leu) supplementation in non-obese, insulin-resistant (IR) rat models, particularly the effects on insulin sensitivity, lipid profile, and antioxidant activity.METHODS:Wistar rats were fed a diet consisting of 38.5% fat for 12 wk and 51.3% fat for an additional 4 wk to establish non-obese IR rats. The IR rats were then switched to regular AIN-93 diet containing 0% WP, 5% WP, 15% WP or 1.6% Leu for 8 wk. The Leu content was the same in the 15% WP and 1.6% Leu groups based on high-performance liquid chromatography. The IR rats' body weight, fasting blood glucose, fasting insulin, and homeostasis model assessment-insulin resistance were measured before and after supplementation. An oral glucose tolerance test was performed after supplementation. Body composition, plasma concentrations of the lipids profile, and antioxidant index also were analyzed.RESULTS:No significant difference was observed in body weight, energy intake, and fasting blood glucose in the non-obese IR rats at the end of the experiment. Compared with the 0% WP group, the fasting insulin and homeostasis model assessment-insulin resistance significantly decreased in the 15% WP and 1.6% Leu groups. Furthermore, the blood glucose area under the curve of the oral glucose tolerance test was significantly less in the 15% WP and 1.6% Leu groups. There were no differences in the lipids profile, except for the increase in the high-density lipoprotein cholesterol in the 15% WP and 1.6% Leu groups. For the antioxidant index, the 15% WP group had significantly increased plasma levels for total antioxidation capacity, superoxide dismutase, and glutathione, and a decreased malondialdehyde concentration. The 1.6% Leu group was shown to have the same effect as the 15% WP group, except for the glutathione.CONCLUSION:Our findings demonstrate that the supplementation of WP and Leu may improve IR and antioxidant stress without resulting in changes in body weight and energy intake in non-obese IR rats.

Leucine supplementation improves leptin sensitivity in high-fat diet fed rats

Chronic Leucine Supplementation Increases Body Weight and Insulin Sensitivity in Rats on High-Fat Diet Likely by Promoting Insulin Signaling in Insulin-Target Tissues

EFFECT OF LEUCINE ON INSULIN SENSITIVITY IN RATS FED A HIGH-FAT DIET

Effect of leucine on leptin resistance in mice fed with high fat/cholesterol diet

Chronic leucine supplementation improves lipid metabolism in C57BL/6J mice fed with a high-fat/cholesterol diet

Leucine Supplementation Increases SIRT1 Expression and Prevents Mitochondrial Dysfunction and Metabolic Disorders in High-Fat Diet-Induced Obese Mice.

Leucine Supplementation Differently Modulates Branched-Chain Amino Acid Catabolism, Mitochondrial Function and Metabolic Profiles at the Different Stage of Insulin Resistance in Rats on High-Fat Diet.

Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms

Effect of Dietary Leucine Supplementation on Plasma Leptin Level and Protein Metabolism of Skeletal Muscles in Rats

Leucine Deprivation Increases Hepatic Insulin Sensitivity Via GCN2/mTOR/S6K1 and AMPK Pathways.

Dietary supplementation with L-leucine reduces nitric oxide synthesis by endothelial cells of rats

Leucine Supplementation in a Chronically Protein-Restricted Diet Enhances Muscle Weight and Postprandial Protein Synthesis of Skeletal Muscle by Promoting the Mtor Pathway in Adult Rats

Leptin Contributes to the Adaptive Responses of Mice to High-Fat Diet Intake Through Suppressing the Lipogenic Pathway.

Leptin limits hepatic lipid accumulation and inflammation via vagal activation of the JAK2-STAT3/AMPK pathway

Effects of Whey Protein and Leucine Supplementation on Insulin Resistance in Non-Obese Insulin-Resistant Model Rats.

Leucine Supplementation Ameliorates Early-Life Programming of Obesity in Rats

Leucine in Obesity: Therapeutic Prospects

Leucine Promotes Leptin Receptor Expression in Mouse C2C12 Myotubes Through the Mtor Pathway.

Leptin Signaling is Required for Leucine Deprivation-enhanced Energy Expenditure*

Leucine and isoleucine have similar effects on reducing lipid accumulation, improving insulin sensitivity and increasing the browning of WAT in high-fat diet-induced obese mice.

Leucine Supplement Mitigates Life-Long Metabolic Defects Induced by Early Weaning in Adult Rats